Intervertebral disc (IVD) degeneration has been considered as the major cause of chronic low back pain. Recent advance in cell therapy using adult stem cells are promising approaches for the treatment of degenerative disc. Our previous study showed that rat bone marrow (BM) mononuclear cells (MNC) were able to survive and differentiate in IVDs for up to 21 days following disc injection (1). The type of BM cells surviving in IVD is unknown as MNC consist of both haemopoietic (CD34+) and non-haemopoietic (CD34-) stem cells. It is also unclear if human BM cells will survive in rodent IVD without immunosuppressive therapy. The present study was aimed to assess whether transplanted CD34+ and CD34-cells from human bone marrow would survive and differentiate in IVDs of a rodent model.
Introduction
Intervertebral disc (IVD) degeneration has been considered as the major cause of chronic low back pain. Recent advance in cell therapy using adult stem cells are promising approaches for the treatment of degenerative disc. Our previous study showed that rat bone marrow (BM) mononuclear cells (MNC) were able to survive and differentiate in IVDs for up to 21 days following disc injection (1) . The type of BM cells surviving in IVD is unknown as MNC consist of both haemopoietic (CD34+) and non-haemopoietic (CD34-) stem cells. It is also unclear if human BM cells will survive in rodent IVD without immunosuppressive therapy. The present study was aimed to assess whether transplanted CD34+ and CD34-cells from human bone marrow would survive and differentiate in IVDs of a rodent model.
Materials and Methods
Human cells preparation: Human BM was collected from consented haematologically normal individuals. MNCs were isolated by Ficoll density centrifugation. CD34-and CD34+ cells were separated from MNCs using magnetic activated cell sorting into CD34 + (purity 89%) and CD34
-cells, and then labelled with Cell Tracker Orange (CTO). Animal experiments: The study was approved by the UNSW animal ethics committee. Twenty-eight male Sprague-Dawley rats weighting 350-400g were used. The intervertebral disc injection procedures were performed under fluoroscopic guidance with a 30 gauge needle. 5-10ul of either CD34+ or CD34-cells in PBS suspension (1x10 7 cells /ml) were injected into each coccygeal disc. For each rat, four discs were injected and one served as control. The rats were euthanased and the discs were harvested at day 1, 10, 21 and 42 post transplantation. Assessment of survival cells: Discs were formalin fixed and both frozen and paraffin sections were prepared for histological and immunofluorescence assays. Survival of human cells was detected by visualization of bright red CTO-fluorescence cells and further conformed by immunostaining with human specific marker to nuclear antigen (HN). Expression of type II collagen was assessed in the transplanted cells using immunofluorescence method. Expression of CD68 and Fas-L were evaluated with Immunohistological staining.
Results

1.
No major histological damage to the IVD as the result of the human cell injection (not show) was seen by standard light microscopy Hematoxylin& Eosin (H&E) staining. 2. Fluorescence microscopy demonstrated significantly decreased number of CTO labelled human CD34+ cells by day 10 and no cells could be detected after day 21 (Fig 1.) . However, the number of CTO+/CD34-cells dropped initially but survived up to Day 42 (Fig 2.) . 3. All CTO+ cells were confirmed to be of human origin by the expression of human specific nuclear antigen (Fig 3.) . 4. Transplanted CTO+/CD34-cells expressed collagen II at day 21 and day 42 (Fig 4.) , but not at day 1 or day 10. 5. Infiltration of CD68+ macrophages were detected in the annulus fibrosis (AF) at day 1 and increased slightly by day 10 (Fig 5.) . In contrast, CD68+ cells were absent in NP at all time points. 6. Fas-L marker CD95 positive cells appeared in both groups at each time point and were mainly distributed around peripheral region of the AF and the NP. The number of Fas-L positive cells increased in the NP by day 10 and 20 after injection compared with the control groups (not shown). 
Discussion and conclusion
To our knowledge, this was the first study to demonstrate that CD34 -cells from human bone marrow but not CD34 + cells survived in rat IVDs for up 42 days. The surviving cells expressed collagen II after 21 days, providing preliminary evidence of differentiation of transplanted human cells in rodent IVDs without requiring immunosuppression. These findings suggest that the CD34 -cells from human bone marrow have a broad differentiation potential and an ability to develop into disc-like cells which provides a potential source for cellular therapy for restoring degenerative disc. In addition, these data provide further in vivo evidence that the nucleus puposus of intervertebral disc contains the properties of a immune privileged site. This relatively immune privileged nature of NP offers an adaptive environment for transplanted xenogenic or allogenic stem cells. 
